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Highlights 15 
 Cats with mild left ventricular (LV) hypertrophy were identified with early hypertrophic 16 
cardiomyopathy (HCM). 17 
 Cats with pre-clinical HCM had inflammatory cell infiltrates and increased collagen content in 18 
the myocardium compared to normal cats. 19 
 An inflammatory process might contribute to the pathogenesis of HCM in cats. 20 
 21 
Abstract 22 
The histological features of feline hypertrophic cardiomyopathy (HCM) have been well 23 
documented, but there are no reports describing the histological features in mild pre-clinical 24 
disease, since cats are rarely screened for the disease in the early stages before clinical signs are 25 
apparent. Histological changes at the early stage of the disease in pre-clinical cats could 26 
contribute to an improved understanding of disease aetiology or progression. The aim of this 27 
study was to evaluate the histological features of HCM in the left ventricular (LV) myocardium 28 
of cats diagnosed with pre-clinical HCM. Clinically healthy cats with normal (n = 11) and pre-29 
clinical HCM (n = 6) were identified on the basis of echocardiography; LV free wall dimensions 30 
(LVFWd) and/or interventricular septal wall (IVSd) dimensions during diastole of 6-7 mm were 31 
defined as HCM, while equivalent dimensions < 5.5 mm were defined as normal. LV myocardial 32 
sections were assessed and collagen content and inflammatory cell infiltrates were quantified 33 
objectively. Multifocal areas of inflammatory cell infiltration, predominantly lymphocytes, were 34 
observed frequently in the left myocardium of cats with pre-clinical HCM. Tissue from cats with 35 
pre-clinical HCM also has a higher number of neutrophils and a greater collagen content 36 
compared with the myocardium from normal cats. The myocardium variably demonstrated other 37 
features characteristic of HCM, including arteriolar mural hypertrophy and interstitial fibrosis 38 
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and, to a lesser extent, myocardial fibre disarray and cardiomyocyte hypertrophy. These results 39 
suggest that an inflammatory process could contribute to increased collagen content and the 40 
myocardial fibrosis known to be associated with HCM. 41 
 42 
Keywords: Feline; Hypertrophic cardiomyopathy; Myocardial fibre disarray; Inflammation; 43 
Collagen  44 
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Introduction 45 
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease characterised by 46 
concentric hypertrophy of the left ventricle (LV). In human beings and cats, HCM is caused by 47 
mutations in genes that encode for the myofilament sarcomeric proteins, Z-disc proteins, 48 
calcium-handling proteins and other protein related to the sarcomere (Ferrantini et al., 2009; 49 
Lehrer and Geeves, 2014). To date, 20 genes with over 400 missense mutations have been 50 
identified in human beings; some of these mutations have strong evidence for pathogenicity, 51 
while others have less evidence (Ferrantini et al., 2009; Tian et al., 2013; Marsiglia and Pereira, 52 
2014). 53 
 54 
In cats, two single nucleotide substitutions in the myosin-binding protein C gene have 55 
been identified, but the broad genetic spectrum in human beings suggests that many sarcomeric 56 
genes could also be implicated for cats (Wess et al., 2010). In both species, there is marked 57 
phenotypic heterogeneity and LV hypertrophy can be global or regional. Papillary muscle 58 
hypertrophy, systolic anterior motion of the mitral valve and/ or left atrial dilatation have also 59 
been identified (Liu et al., 1981; Kittleson et al., 1999; Fox, 2003). In cats, the functional 60 
implications of this pathology include diastolic dysfunction that can result in congestive heart 61 
failure, systemic thromboembolism and fatal arrhythmias (Fox et al., 1995). 62 
 63 
In human beings, the mechanism by which the genetic mutation in the sarcomere 64 
translates to the phenotype remains poorly understood. Direct investigation of the effect of the 65 
HCM sarcomeric mutation is difficult because human tissue is limited to autopsy samples of 66 
patients with terminal disease, small biopsy samples, or myectomised tissue from patients with 67 
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LV outflow tract obstruction. For the latter, tissue samples are modified by secondary changes 68 
associated with altered haemodynamic and mechanical stress independent of the disease-causing 69 
mutation. While transgenic mouse models afford more readily accessible tissue, the HCM 70 
phenotype in this species develops without LV outflow tract obstruction and microvascular 71 
pathology (Maass and Leinwand, 2000; Shephard and Semsarian, 2009). Studies of the 72 
pathogenesis of feline HCM from sarcomeric mutation to phenotypic expression are lacking and 73 
histological description is limited to post-mortem investigations of cats with severe and 74 
spontaneously terminal disease (Liu et al., 1981, 1993; Fox et al., 1995; Kittleson et al., 1999). 75 
 76 
As in human beings, a post-mortem diagnosis of feline HCM is based on the 77 
identification of a hypertrophied, non-dilated LV and an increase in absolute and relative heart 78 
weight (Liu et al., 1993). Histological changes of LV myocardial tissue stained with 79 
haematoxylin and eosin (H&E) include myocardial fibre disarray, intramural coronary 80 
arteriosclerosis and myocardial fibrosis (Liu et al., 1981, 1993; Kittleson et al., 1999; Fox, 2003). 81 
Cardiomyocytes have been described as hypertrophied, with large, rectangular, hyperchromic 82 
nuclei (Fox, 2003), but similar changes have not been identified in cats with HCM (Kershaw et 83 
al., 2012). 84 
 85 
The aim of the present study was to report the LV histological changes in cats with pre-86 
clinical HCM compared to normal cats. Additional staining techniques were utilised to 87 
quantitatively assess the LV myocardium of cats with pre-clinical HCM for collagen content and 88 
infiltration by inflammatory cells. 89 
 90 
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Materials and methods 91 
Animals 92 
Un-owned cats scheduled for euthanasia were obtained from a local animal shelter; their 93 
use was approved by the University of Queensland Animal Ethics Committee (approval number 94 
SVS/040/09). Cats that appeared overtly healthy and were considered to be normal on clinical 95 
examination (n = 28) were sedated SC with 0.1 mg/kg acepromazine (ACP 2, Delvet) and 0.1 96 
mg/kg hydromorphone (Dilaudid, Mundipharma) for echocardiography. Cats without cardiac 97 
disease and those with pre-clinical HCM were then recruited for further study. 98 
 99 
Normal cats 100 
Cats were identified as normal if the following criteria were met: (1) physical 101 
examination was unremarkable, they were well hydrated and had a body condition score of 3-5/5 102 
(Laflamme, 1997); (2) thoracic auscultation identified a regular heart rhythm and no heart 103 
murmur; (3) six-lead electrocardiogram identified normal sinus rhythm or sinus tachycardia with 104 
a mean electrical axis between -10° and +140° (Harvey et al., 2005); and (4) echocardiography 105 
identified LV wall symmetry from the right parasternal short-axis view by continuous base-to-106 
apical sweep with LV free wall (LVFWd) and interventricular septal wall (IVSd) dimensions 107 
during diastole of <5.5 mm (Fox et al., 1995), left atrial (LA) to aortic (Ao) root ratio (LA:Ao) < 108 
1.37 (Abbott and MacLean, 2006), subjectively normal right heart with no more than trivial 109 
insufficiencies of the pulmonic and tricuspid valves, no insufficiency of the aortic and mitral 110 
valves, ventricular outflow velocities determined by pulsed-wave Doppler echocardiography of < 111 
1.5 m/s and pulsed-wave tissue Doppler velocity of the lateral mitral valve annulus determined 112 
from the left apical four-chamber view of > 5.8 cm/s (Koffas et al., 2006). 113 
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 114 
Cats with pre-clinical hypertrophic cardiomyopathy 115 
Cats were identified as having pre-clinical HCM if the following criteria were met: (1) 116 
physical examination was unremarkable and body condition score was 3-5 (Laflamme, 1997); 117 
(2) thoracic auscultation was unremarkable or identified a systolic heart murmur of grade IV/VI 118 
or less; (3) six-lead electrocardiogram identified normal sinus rhythm or sinus tachycardia 119 
irrespective of mean electrical axis (Harvey et al., 2005) and; (4) echocardiography identified 120 
LVFWd and/ or IVSd dimensions during diastole of 6-7 mm (MacDonald et al., 2006), LA:Ao 121 
ratio > 1.37 (Abbott and MacLean, 2006), subjectively normal right heart with no more than 122 
trivial insufficiencies of the pulmonic and tricuspid valves, no insufficiency of the aortic valve 123 
and right ventricular outflow velocity determined by pulsed-wave Doppler < 2.4 m/s (Rishniw 124 
and Thomas, 2002). 125 
 126 
Echocardiography 127 
Echocardiographic (Phillips iE33, Phillips Healthcare) examination was performed with 128 
the cat lightly restrained in lateral recumbency on a purpose-designed table, which allowed 129 
placement of the transducer (12 MHz) on the dependent side of the thorax. Electrodes attached to 130 
the skin overlying the stifles and right elbow allowed the simultaneous recording of a lead II 131 
electrocardiogram (ECG) that was displayed on the ultrasound monitor. All examinations were 132 
performed by the same experienced echocardiographer (FEC). 133 
 134 
Dimensional measurements of the LV were made from a right parasternal short axis view 135 
(Thomas et al., 1993) at the level of the papillary muscles from two-dimensional short-axis 136 
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images using the leading-edge method (Sahn et al., 1978) and included IVSd and LVFWd and 137 
the internal diameter of the LV in diastole and systole (LVIDd and LVIDs, respectively). 138 
Calipers were positioned at the onset of the QRS complex on the simultaneously recorded ECG 139 
for determination of diastolic measurements. Systolic measurements were made from the frame 140 
with smallest chamber dimension immediately preceding ventricular expansion. 141 
 142 
Using a modification of a previously described technique (Rishniw and Erb, 2000), LA 143 
and aortic root (Ao) dimensions were determined from a right parasternal two-dimensional short-144 
axis view at the heart base by directing the calipers in a line along the commissure between the 145 
non-coronary and the left coronary aortic valve cusps through the Ao and LA. All LA and Ao 146 
measurements were determined immediately preceding atrial systole at the onset of the P wave 147 
on the ECG (Abbott and MacLean, 2006). 148 
 149 
Echocardiographic examination also included colour-flow Doppler assessment of all 150 
valves and pulsed-wave Doppler assessment of both outflow tracts to identify any significant 151 
valvular insufficiencies or outflow obstruction suggestive of non-HCM cardiac disease and to 152 
quantify peak LV outflow tract velocity when systolic anterior motion of the mitral valve was 153 
present with HCM. 154 
 155 
Transmitral flow was recorded from the left apical four-chamber view with the 2 mm 156 
pulsed-wave sample volume placed between the tips of the open mitral leaflets. Peak early (peak 157 
E) and late (peak A) diastolic flow wave velocities were measured. When rapid heart rates 158 
produced E and A wave summation, peak velocity of the summed waveform (summed EA) was 159 
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recorded. Pulsed-wave tissue Doppler imaging of the LV myocardium was used to determine 160 
early (Peak E’) and late (Peak A’) diastolic velocity of the lateral mitral annulus from the left 161 
parasternal four-chamber view. When rapid heart rates produced E’ and A’ wave summation, 162 
peak velocity of the summed waveform (summed E’A’) was recorded. For tissue Doppler 163 
imaging, the gate of the 12 MHz transducer was placed perpendicular to myocardial movement, 164 
the Nyquist limit was set at 10-15 cm/s, sweep speed was 160 cm/s and the filter was set at 50 165 
MHz (Koffas et al., 2006). All measures were made from four to five consecutive cardiac cycles 166 
and averaged. 167 
 168 
Selection and preparation of tissue sections 169 
Hearts were collected, sectioned and prepared according to a standardised protocol. Cats 170 
were humanely euthanased by sodium pentobarbitone (30 mg/kg IV; Lethabarb Euthanasia 171 
Injection, Virbac) and heparin was administered (320 IU/kg IV) to prevent thrombosis. Right 172 
thoracotomy was immediately performed and the heart was excised from the mediastinum, and 173 
peripheral fat and loose connective tissue were removed. The wet heart weight was recorded, 174 
then the LV was excised, weighed and fixed in 10% neutral buffered formalin. 175 
 176 
Full thickness tissue sections of the LV were taken perpendicular to the long axis of the 177 
LV from: (1) the IVS at the point of maximal thickness, and (2) the posterior LVFW about one-178 
half the distance between the mitral valve annulus and the LV apex. These sections were 179 
dehydrated in graded ethanol series, embedded in paraffin wax and processed for histopathology. 180 
Sections with a thickness of 10 µm for picrosirius red staining, and 6 µm for H&E and Leder 181 
(chloroacetate esterase) staining, were mounted onto slides. 182 
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 183 
Routine histopathological examination 184 
LV tissues stained with H&E from normal cats (n = 11) and cats with pre-clinical (n = 6) 185 
HCM were evaluated histologically by a single blinded veterinary pathologist (HO). Subjective 186 
description of tissue sections included: (1) semi-quantification of myocardial fibre disarray 187 
visually estimated as absent (occupying < 5% or 5-15% of the tissue section); (2) presence or 188 
absence of myocyte hypertrophy (assessed subjectively as number fold increase in fibre diameter 189 
compared to normal healthy tissues), fragmentation and vacuolation; (3) presence or absence, 190 
type and degree of infiltrative leucocytes; (4) Subjective description of arteriosclerosis with 191 
mural thickening of the small arterioles and the presence or absence of arteriole thrombi; and (5) 192 
presence or absence of myocardial fibrosis. 193 
 194 
Quantification of collagen by picrosirius red stain staining 195 
Dehydrated tissue sections (10 µm thickness) from normal cats and cats with pre-clinical 196 
HCM were rehydrated by immersion in lithium carbonate (saturated in distilled water) for 3 min. 197 
Slides were rinsed in a water bath (5 min) and washed in distilled water (30 s) before being 198 
immersed in phosphomolybdic acid (0.2% in distilled water, 4 min) to reduce non-specific 199 
binding of the stain to the section. After rinsing in distilled water, slides were transferred into the 200 
picrosirius red stain (0.1% sirius red F3BA in saturated picric acid) and incubated for 45 min. 201 
Slides were then placed in 0.01 M hydrochloric acid for 2 min, removed and mounted on Depex 202 
with a cover slip and allowed to dry overnight (Allan et al., 2005). Analysis of stained sections 203 
was performed using a laser-scanning confocal microscope (Model LSM 510 Meta, Carl Zeiss) 204 
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with a HeNel laser. Slides were exposed to a red filter (excitation wavelength of 543 nm, 205 
emission wavelength of 560-615 nm). 206 
 207 
Since any fibrosis in the normal and pre-clinical cases appeared to be relatively uniform 208 
in distribution on the basis of examination of H&E sections, five randomly selected regions of 209 
each tissue section were chosen for evaluation. Images were acquired at 40x magnification and 210 
analysed for pixel intensity to ascertain the extent of collagen deposition. The data were 211 
compiled using Image J software (National Institute of Health). Collagen deposition, given as a 212 
percentage of tissue evaluated, was averaged from five images (Fenning et al., 2005). 213 
 214 
Identification and quantification of neutrophils 215 
Tissue sections (6 µm thickness) from normal cats and cats with pre-clinical HCM were 216 
stained by the Leder method using the 91C-1KT - Naphthol AS-D Chloroacetate (Specific 217 
Esterase) Kit (Sigma-Aldrich) to identify and quantify neutrophilic infiltrates (other myeloid 218 
cells and mast cells will also take up this stain). The total number of neutrophils per 400x field 219 
were counted in 20 randomly selected fields; data is provided as total number of neutrophils per 220 
cat. 221 
 222 
Statistical analysis 223 
Statistical analysis was performed using SPSS 16 (IBM). Results are reported as medians 224 
and interquartile ranges (IQR), since the data were not normally distributed. Wilcoxon’s rank 225 
sum test was used to identify differences between the two groups. P values < 0.05 were 226 
considered to be statistically significant. 227 
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 228 
Results 229 
Animals 230 
Normal cats - Eleven cats (seven males and four females) were identified as normal for 231 
inclusion in the study. Age was unknown, but all appeared to be young adults (n = 4) or middle-232 
aged (n = 7). Breeds represented included Domestic short hair (n = 10) and Domestic longhair (n 233 
= 1). The median interventricular septum and left ventricular free wall thicknesses at diastole 234 
were 4.1 mm (IQR 3.6-4.75 mm) and 4.1 mm (IQR 3.8-4.9 mm), respectively. 235 
 236 
Cats with pre-clinical hypertrophic cardiomyopathy - Pre-clinical HCM was identified by 237 
echocardiography in six cats (four males and two females). Age was subjectively assessed as 238 
young adult (n = 2) and middle-aged (n = 4). Breeds represented included Domestic short hair (n 239 
= 4), Domestic long hair (n = 1) and British blue (n = 1). The median interventricular septum and 240 
left ventricular free wall thicknesses at diastole were 6.0 mm (IQR 6.0-6.6 mm) and 6.3 mm 241 
(IQR 5.8-6.4 mm), respectively. No murmur was noted in any of the cats on auscultation. 242 
 243 
Echocardiographic examination 244 
Cats with pre-clinical HCM had increased IVSd and LVFWd dimensions compared to 245 
normal cats. LA dimensions of cats with pre-clinical HCM were within the limits of normal 246 
(Abbott and MacLean, 2006) and comparable to the LA of normal cats in this study (Table 1). In 247 
comparison with normal cats, cats with pre-clinical HCM had a significantly reduced LVIDs and 248 
increased contractility (P = 0.043). There was no difference in the heart rate, LVIDd, Ao, LA or 249 
La:Ao ratio (Table 1). Peak E, Peak A, E:A ratio, Peak E’ and Peak A’ values are shown in 250 
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Table 1 but were not analysed due to the small sample size. The summed early and late diastolic 251 
velocity (summed E’A’) was not significantly reduced (P = 0.102) in cats with pre-clinical 252 
HCM, compared to normal cats (Table 1). 253 
 254 
Gross pathology 255 
Normal cats and cats with pre-clinical HCM had similar bodyweights (BWs), total wet 256 
heart weights and LV weights (Table 2). Heart weight:BW ratio and LV:total heart weight ratio 257 
did not differ between normal cats and cats with pre-clinical HCM (P > 0.05). 258 
 259 
Histopathology 260 
 Tissue sections from normal cats (Fig. 1) did not demonstrate any evidence of myocardial 261 
fibre disarray. Similarly, the myocytes were histologically normal, with no hypertrophy, 262 
fragmentation or vacuolation. Rare isolated lymphocytes were identified in LV tissue of all 263 
normal cats. Small arterioles appeared to be structurally normal in all samples, with no evidence 264 
of intraluminal thrombi. 265 
 266 
Tissue sections from 2/6 cats with pre-clinical HCM demonstrated small areas (<5% of 267 
sections examined) of mild myocardial fibre disarray and all cats demonstrated mild (up to 1.5 268 
fold) myocyte hypertrophy, but myocyte fragmentation and vacuolation was not apparent. 269 
Multifocal regions up to 0.8 mm in diameter containing neutrophils, along with dense 270 
populations of lymphocytes, plasma cells and macrophages, were identified in the LV 271 
myocardium of 4/6 cats (Fig. 2). The free wall and interventricular septum were both affected in 272 
2/6 cats. All affected tissues had mid-myocardial inflammatory cell aggregates; in cases where 273 
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both the free wall and interventricular septum were affected, the free wall also had sub-epicardial 274 
aggregates. Up to 10% of the tissue in the section was affected. Mild to moderate mural 275 
hypertrophy of small arterioles (up to ~290 µm in diameter) was identified in all cats with HCM 276 
but no intraluminal thrombi were identified (Fig. 3). In the septum and free wall of 5/6 cats with 277 
pre-clinical disease, there were small multifocal areas where the interstitium was minimally 278 
expanded by fibroplasia. 279 
 280 
Quantification of collagen 281 
Collagen content was increased in LV myocardial tissue from cats with pre-clinical HCM 282 
(P < 0.001) compared to myocardial tissue from normal cats (Figs. 4 and 5). 283 
 284 
Quantification of neutrophils 285 
Neutrophils were identified in the LV myocardium from 3/11 normal cats and all six cats 286 
with pre-clinical HCM (Fig. 6). Tissue from cats with pre-clinical HCM (P < 0.01) had 287 
comparably increased neutrophil counts relative to tissue from normal cats (Fig. 7). 288 
 289 
Discussion 290 
This study demonstrated that the histological features of HCM, including myocardial 291 
fibre disarray and cardiomyocyte hypertrophy, arteriolar mural hypertrophy and interstitial 292 
fibrosis (Liu et al., 1981, 1993), were present in the LV myocardium of cats with 293 
echocardiographic evidence of pre-clinical HCM, thus supporting the echocardiographic 294 
diagnosis. In addition, increased collagen deposition and neutrophilic and lymphocytic infiltrates 295 
were found in the myocardium of cats in the pre-clinical HCM group. 296 
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 297 
The development of cardiomyocyte hypertrophy and gross LV concentric hypertrophy in 298 
HCM is poorly understood. The varied sarcomeric defects of HCM generally result in increased 299 
myofibrillar calcium sensitivity. Increased rate of calcium binding to troponin C and faster cross-300 
bridge turnover rate suggest that HCM gene mutations result in a hyper-contractile cardiac 301 
phenotype (Marston, 2011). The resulting alteration in mechanosensation and 302 
mechanotransduction, together with a gross energy deficiency arising from impaired thermal 303 
efficiency in HCM may promote compensatory hypertrophy. Diastolic dysfunction can result 304 
directly from altered calcium cycling (Fatkin et al., 2000) or, indirectly, as a result of LV 305 
hypertrophy, promoting fibrosis and disorganisation of the connective tissue matrix (Factor et al., 306 
1991). 307 
 308 
Intimal hyperplasia and medial hypertrophy of the intramural coronary arteries has been 309 
identified to a variable degree in both human beings and cats with HCM, and was identified in 310 
the present study in cats with mild pre-clinical HCM. Affected arteries are found in both 311 
hypertrophied and non-hypertrophied regions of the LV, but more extensively in human beings 312 
with HCM than those with LV hypertrophy due to non-HCM diseases. This finding suggests that 313 
arterial pathology represents a primary constituent of the cardiomyopathic process rather than 314 
developing secondary to elevated intramyocardial wall tension (Maron et al., 1986; Cecchi et al., 315 
2009). The arterial pathology, particularly when coupled with micro-thrombi, results in luminal 316 
narrowing which limits coronary blood flow, with the subsequent potential for myocardial 317 
ischaemia, necrosis and replacement fibrosis (Maron et al., 1986; Liu et al., 1993; Cecchi et al., 318 
2009). 319 
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 320 
The reduced capillary density in the hypertrophic myocardium and the increased oxygen 321 
demand of hypertrophic cardiomyocytes might provide an additional mechanism for ischaemia 322 
and secondary fibrosis in HCM (Maron et al., 1986; Liu et al., 1993; Cecchi et al., 2009). A 323 
relationship between regional ischaemia and fibrosis is supported by the spatial association of 324 
affected arteries and fibrotic tissue in the current and previous histological studies (Liu et al., 325 
1981; Maron et al., 1986). Impaired myocardial perfusion has been identified in regions of 326 
fibrosis in humans with HCM, further supporting the theory that coronary microvascular 327 
dysfunction induces myocardial fibrosis in HCM (Sotgia et al., 2008). 328 
 329 
The inflammatory cell infiltration affecting up to 10% of the myocardium in pre-clinical 330 
cats in the current study was considered to be significant, since no such inflammatory cell 331 
aggregations were noted in control cats. The proximity of lymphocyte infiltrates and fibrosis 332 
suggests that myocardial fibrosis in HCM could be an active process that is modified by an 333 
inflammatory response. Cytokines released from these inflammatory cells, including interleukin 334 
(IL)-1, IL-6 and tumour necrosis factor (TNF)-α might play a role in myocardial remodelling and 335 
further fuel the inflammatory process. TNF-α, via regulation of matrix metalloproteinases 336 
(MMPs) and tissue inhibitors of MMPs, modulates the balance between extracellular matrix 337 
synthesis and degradation, and might contribute to the fibrosis identified in cats with HCM 338 
(Sivasubramanian et al., 2001). Studies of human patients with mild HCM have identified 339 
elevated circulating TNF-alpha, IL-1, IL-6, IL-10 (Hogye et al., 2004; Kuusisto et al., 2012). 340 
 341 
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A correlation between fibrosis and infiltration of the myocardium by T cells and 342 
eosinophils has been identified in HCM patients (Kuusisto et al., 2012). Similarly, inflammatory 343 
cell infiltrates are identified in the myocardium of human patients with early arrhythmogenic 344 
right ventricular cardiomyopathy and are thought to facilitate progressive myocardial necrosis 345 
and replacement fibrosis (Fox et al., 2000; Gemayel et al., 2001; Basso et al., 2004). 346 
 347 
Several stimuli for inflammatory cell infiltration of the myocardium in cats with HCM 348 
are possible. Altered mechanical stress with HCM could induce inflammatory cytokine 349 
expression, as demonstrated in a rat model of hypertensive LV hypertrophy (Shioi et al., 1997). 350 
Hypoxia and ischaemia are also potent inducers of inflammatory cytokines, including TNF-α, 351 
IL-8 and monocyte chemoattractant peptide (Aukrust et al., 2005). In human patients with 352 
arrhythmogenic right ventricular cardiomyopathy, it has been proposed that subclinical viral 353 
myocarditis initiates inflammatory infiltrates and is necessary to facilitate gene expression and 354 
provoke phenotypic manifestation of this genetic disease (Gemayel et al., 2001). 355 
 356 
In the present study, heart weight lacked sensitivity as an absolute criterion for the post-357 
mortem diagnosis of pre-clinical HCM. An ante mortem diagnosis of HCM in cats is made via 358 
echocardiography by identification of diastolic LV wall thickness > 6 mm. At post-mortem 359 
examination, hallmark histological findings, and increased absolute and relative heart weight, are 360 
consistent with a diagnosis of HCM (Liu et al., 1981; Fox, 2003). However, in the cats in this 361 
study with mild pre-clinical HCM, characterised by mild LV hypertrophy and normal left atrial 362 
size, the gross heart weight was similar to normal cats. This is likely to reflect the greater 363 
sensitivity of two-dimensional and tissue Doppler echocardiography in detecting mild 364 
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hypertrophy and diastolic dysfunction. Although the number of cats in our study was small, this 365 
finding suggests that HCM cannot be excluded on the basis of normal absolute or relative heart 366 
weight at post-mortem examination. 367 
 368 
There are several limitations to this study, including the wide age range at which cats 369 
with HCM are commonly represented. In our study, normal cats and those with mild HCM were 370 
typically young to middle-aged, so it was not possible to determine if there was any degenerative 371 
component among histological changes as reported in older cats with HCM. Systemic blood 372 
pressure and serum thyroid concentrations were not assessed in cats with pre-clinical HCM; as a 373 
consequence, LV hypertrophy secondary to hypertension and hyperthyroidism, rather than 374 
primary HCM, cannot be excluded. Cats were allocated to the ‘pre-clinical HCM’ group on the 375 
basis of echocardiographic findings suggestive of HCM (diastolic LVFWd and/or IVSd 376 
dimensions of 6-7 mm; Fox et al., 1995; MacDonald et al., 2006). These echocardiographic 377 
findings could also occur with systemic hypertension, hyperthyroidism, acromegaly and 378 
dehydration (Campbell and Kittleson 2007), which were not excluded in the present study; 379 
however, the histological features in the pre-clinical HCM group were consistent with HCM, 380 
indicating that our classification was appropriate. Furthermore, the possibility cannot be 381 
excluded that the inflammatory infiltrates might represent myocarditis in a hypertrophic left 382 
ventricle in cats where the cause of the hypertrophy is not HCM. 383 
 384 
Conclusions 385 
This study identified inflammatory cell infiltrates and increased collagen in the 386 
myocardium of cats with mild pre-clinical HCM. Cats with pre-clinical HCM had mild LV 387 
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hypertrophy with histological findings indicating possible HCM in the early stage of the disease. 388 
It would be interesting to determine if this observation is the same in cats with more severe 389 
HCM. Further studies that include immunohistochemical myocardial staining and evaluate 390 
circulating inflammatory cytokines are indicated to better characterise the role of inflammation 391 
in the pathogenesis and early development of fibrosis in feline HCM. 392 
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Figure legends 558 
 559 
Fig. 1. Representative photomicrographs of left ventricular (LV) myocardium (excluding the 560 
junction of the interventricular septum and LV free wall) from (A) a normal cat with normal 561 
myofibres and (B) a cat with pre-clinical hypertrophic cardiomyopathy, the latter demonstrating 562 
an area of myocardial fibre disarray with disordered arrangement of cardiac muscle cells at 563 
oblique angles to each other (haematoxylin and eosin stain). Scale bar = 60 μm. 564 
 565 
Fig. 2. Representative photomicrographs of the left ventricular (LV) myocardium from normal 566 
cats and cats with pre-clinical hypertrophic cardiomyopathy (HCM) stained with haematoxylin 567 
and eosin (A, B and C) and Leder stain (D and E) for inflammatory infiltrates. (A and D) 568 
Myocardial tissue from a normal cat. (B, C and E) Myocardium from the interventricular septum 569 
and LV free wall from a cat with pre-clinical HCM, demonstrating multifocal inflammatory cell 570 
infiltration consisting predominantly of lymphocytes. A, D and E: scale bar = 370 μm; 571 
B: scale bar = 550 μm; C: scale bar = 150 μm. 572 
 573 
Fig. 3. Representative photomicrographs of (A) normal and (B) hypertrophied arterioles in the 574 
left ventricular myocardium from cats with pre-clinical hypertrophic cardiomyopathy stained 575 
with haematoxylin and eosin (scale bars = 125 μm). The arteriole in Fig. B has plump reactive 576 
endothelium and expansion of the tunica intima. 577 
 578 
Fig. 4. Representative photomicrographs of left ventricular (LV) myocardial tissue obtained from 579 
normal cats and cats with pre-clinical hypertrophic cardiomyopathy (HCM), demonstrating 580 
collagen content (arrows; stained with picrosirius red; magnification 400x). Top row, 581 
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interventricular septum (IVS; A and B) and LV free wall (LVFW; C and D) from a normal cat; 582 
second row, IVS (E and F) and LVFW (G and H) of the LV from a cat with pre-clinical HCM, 583 
showing increased deposition of collagen (white arrows). Scale bars = 60 μm. 584 
 585 
Fig. 5. Percentage collagen deposition in the interventricular septum (IVS) and left ventricular 586 
free wall (LVFW) myocardium of normal cats and cats with pre-clinical hypertrophic 587 
cardiomyopathy (HCM). * P < 0.05. 588 
 589 
Fig. 6. Representative image of the left ventricular myocardium of a cat with pre-clinical 590 
hypertrophic cardiomyopathy, demonstrating neutrophils (arrows) between myofibres (Leder 591 
stain). Scale bar = 125 μm. 592 
 593 
Fig. 7. Number of neutrophils per tissue section in the left ventricular myocardium of normal 594 
cats and cats with pre-clinical hypertrophic cardiomyopathy (HCM). * P < 0.05. 595 
 596 
 597 
Table 1 598 
Median (interquartile range, IQR) of echocardiographic measures for normal cats and cats with 599 
pre-clinical hypertrophic cardiomyopathy (HCM). 600 
 601 
 Normal cats 
(n = 10) 
Cats with pre-clinical HCM 
(n = 6) 
P 
Heart rate (bpm) 226 (193-237) 223 (198-232) 0.500 
LVIDd (mm) 12.6 (11.1-13.7) 10.7 (10.5-13.0) 0.225 
LVIDs (mm) 6.9 (6.2-8.4) 5.1 (1.9-6.0) 0.043 
FS (%) 40.7 (37.9-44.6) 55.3 (45.8-84.2) 0.043 
Ao (mm) 8.8 (8.2-9.3) 8.9 (7.8-10.2) 0.893 
LA (mm) 10.7 (9.6-11.0) 10.7 (9.7-11.8) 0.686 
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LA:Ao 1.18 (1.13-1.28) 1.18 (1.11-1.26) 0.893 
Peak E (m/s) 0.6 (0.57-0.77) 0.49 (0.34-0.59)
a
 - 
b
 
Peak A (m/s) 0.35 (0.16-0.45) 0.71 (0.68-0.75)
 a
 - 
E:A 0.98 (0.93-1.14) 0.69 (0.45-0.87)
 a
 - 
Peak E’ (cm/s) 1.25 (0.73-2.52) 0.55 (0.38-0.45)
 a
 - 
Peak A’ (cm/s)  0.7 (0.48-1.43) 0.9 (0.6-0.75)
 a
 - 
Summed E’A’ (cm/s) 1.10 (0.90-1.20) 8.50 (0.70-0.95) 0.102 
 602 
a
 n = 2. 603 
b
 Not analysed. 604 
bpm, beats per min; LVIDd, left ventricular internal diameter in diastole; LVIDs, left ventricular internal diameter in 605 
systole; FS, fractional shortening; Ao, aorta; LA, left atrium; LA:Ao, left atrium aortic root ratio, Peak E, peak 606 
velocity of early diastolic transmitral flow wave (E-wave); Peak A, peak velocity of late diastolic transmitral flow 607 
wave (A-wave); E:A, ratio of Peak E to Peak A; Peak E’, peak velocity of early diastolic mitral annulus motion; 608 
Peak A’, peak velocity of late diastolic mitral annulus motion; Summed E’A’, summation of velocity of Peak E’ and 609 
Peak A’.610 
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Table 2 611 
Median (interquartile range, IQR) of bodyweight (BW) and heart weight of normal cats and cats 612 
with pre-clinical HCM. 613 
 614 
Weight  Normal 
 (n = 11) 
Pre-clinical HCM
 
 (n = 6) 
P 
BW (kg) 3.5 (3.2-5.4.3) 3.5 (3.2-4.3) 0.600 
Wet heart weight (g) 14.4 (12.0-15.7) 16.2 (14.7-17.5) 0.028 
Wet LV weight (g) 10.9 (8.6-11.7) 11.3 (9.9-14.3) 0.345 
Heart weight:BW (g/kg) 3.9 (3.8-4.2) 4.2 (3.9-4.5) 0.917 
LV weight:heart weight (g/g) 0.66 (0.65-0.75) 0.74 (0.62-0.78) 0.248 
 615 
LV, Left ventricle. 616 
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